These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19428927)

  • 1. Intracameral voriconazole: in vitro safety for human ocular cells.
    Kernt M; Kampik A
    Toxicology; 2009 Apr; 258(2-3):84-93. PubMed ID: 19428927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracameral moxifloxacin: in vitro safety on human ocular cells.
    Kernt M; Neubauer AS; Liegl RG; Lackerbauer CA; Eibl KH; Alge CS; Ulbig MW; A AK
    Cornea; 2009 Jun; 28(5):553-61. PubMed ID: 19421040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
    Kernt M; Neubauer AS; De Kaspar HM; Kampik A
    Retina; 2009 Mar; 29(3):362-70. PubMed ID: 18997637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.
    Kernt M; Neubauer AS; Ulbig MW; Kampik A; Welge-Lüssen U
    J Cataract Refract Surg; 2008 Mar; 34(3):480-8. PubMed ID: 18299076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular caspofungin: in vitro safety profile for human ocular cells.
    Kernt M; Kampik A
    Mycoses; 2011 Jul; 54(4):e110-21. PubMed ID: 20202116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].
    Kernt M; Hirneiss C; Neubauer AS; Liegl RG; Eibl KH; Wolf A; de Kaspar H; Ulbig MW; Kampik A
    Ophthalmologe; 2010 Aug; 107(8):720-7. PubMed ID: 19756636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of voriconazole on corneal endothelial cells in an animal model.
    Han SB; Yang HK; Hyon JY; Shin YJ; Wee WR
    Br J Ophthalmol; 2012 Jun; 96(6):905-8. PubMed ID: 22389199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].
    Thiele S; Liegl RG; König S; Siedlecki J; Langer J; Eibl K; Haritoglou C; Kampik A; Kernt M
    Klin Monbl Augenheilkd; 2013 Mar; 230(3):247-54. PubMed ID: 23508753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant.
    Huhtala A; Rönkkö S; Teräsvirta M; Puustjärvi T; Sihvola R; Vehanen K; Laukkanen A; Anttila J; Urtti A; Pohjonen T; Uusitalo H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2216-23. PubMed ID: 19136700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.
    Kim SY; Yang J; Lee YC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):315-8. PubMed ID: 20698796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of quercetin against oxidative stress in the human RPE in vitro.
    Kook D; Wolf AH; Yu AL; Neubauer AS; Priglinger SG; Kampik A; Welge-Lüssen UC
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1712-20. PubMed ID: 18385095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal endothelial cell survival in organ cultures under acute oxidative stress: effect of VIP.
    Koh SW; Waschek JA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4085-92. PubMed ID: 11095600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue.
    Ritterband DC; Shah MK; Meskin SW; Seedor JA; Koplin RS; Perez W; Yang R; Hu DN; Dahl P
    Cornea; 2007 Apr; 26(3):343-7. PubMed ID: 17413963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of voriconazole on cultured human corneal endothelial cells.
    Han SB; Shin YJ; Hyon JY; Wee WR
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4519-23. PubMed ID: 21768517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells].
    Kernt M; Welge-Lüssen U; Yu A; Neubauer AS; Kampik A
    Ophthalmologe; 2007 Nov; 104(11):965-71. PubMed ID: 17653724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole in the treatment of fungal eye infections: a review of current literature.
    Hariprasad SM; Mieler WF; Lin TK; Sponsel WE; Graybill JR
    Br J Ophthalmol; 2008 Jul; 92(7):871-8. PubMed ID: 18577634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-related effects of oxidant-induced stress on cultured RPE and choroidal endothelial cells.
    Eichler W; Reiche A; Yafai Y; Lange J; Wiedemann P
    Exp Eye Res; 2008 Oct; 87(4):342-8. PubMed ID: 18640112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.